Market Overview

Stocks Hitting 52-Week Highs

Related CYMI
Korean Regulator Approves ASML Acquisition of Cymer
Earnings Scheduled For February 15, 2013
Related ACAD
ACADIA Pharmaceuticals Announces Stephen Davis As Executive VP, CFO And Chief Business Officer
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

Cymer (NASDAQ: CYMI) shares jumped 1.14% to create a new 52-week high of $84.90. Cymer shares have surged 105.08% over the past 52 weeks, while the S&P 500 index has gained 17.66% in the same period.

ACADIA Pharmaceuticals (NASDAQ: ACAD) shares gained 156.96% to touch a new 52-week high of $5.91. ACADIA Pharmaceuticals reported successful top-line results from its pivotal Phase III Parkinson's disease psychosis trial.

Unilever NV (NYSE: UN) shares rose 0.86% to create a new 52-week high of $37.55. Unilever's trailing-twelve-month ROE is 30.21%.

Brown Shoe Co (NYSE: BWS) shares gained 2.60% to create a new 52-week high of $18.13. Brown Shoe's PEG ratio is 1.09.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (ACAD + BWS)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters

Benzinga Professional